Skip to Content
Merck
All Photos(1)

Key Documents

P5367

Sigma-Aldrich

Anti-Par-4 (Prostate Apoptosis Response-4) antibody produced in rabbit

IgG fraction of antiserum, buffered aqueous solution

Sign Into View Organizational & Contract Pricing


About This Item

MDL number:
UNSPSC Code:
12352203
NACRES:
NA.46

biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

IgG fraction of antiserum

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous solution

mol wt

antigen 38 kDa

species reactivity

human, rat, mouse

technique(s)

microarray: suitable
western blot: 1:1,000 using whole cell extract of the mouse fibroblast NIH3T3 cell line
western blot: 1:5,000 using whole cell extract of the human HeLa cell line

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... PAWR(5074)
mouse ... Pawr(114774)
rat ... Pawr(64513)

General description

PRKC apoptosis WT1 regulator protein (PAWR) is also known as prostate apoptosis response 4 protein (Par-4). The PAWR gene is mapped to human chromosome 12q21.2. It is a 40 kDa protein expressed ubiquitously in mammals. It was first identified in prostate tumors.It has a leucine zipper domain and nuclear localization sequences. A core domain comprising of region 137-195 amino acids is critical for the apoptotic function of PAR-4. It interacts and modulates the activity of protein kinase C.

Immunogen

synthetic peptide corresponding to the C-terminus of human Par-4 (amino acids 324-342) conjugated to KLH.

Application

Anti-Par-4 (Prostate Apoptosis Response-4) antibody produced in rabbit may be used in immunoblotting.

Biochem/physiol Actions

Par-4 protein interacts with Wilm′s tumor suppressor WT1 and modulates its transcription and growth suppression function. The gene for Par-4 is down-regulated by oncogenic Ras via the Raf-1- mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK-ERK) pathway in immortalized fibroblasts. Overexpression of the PAR4 gene causes down-regulation of B-cell lymphoma-2 (Bcl-2) in fibroblasts and prostate cancer cells. Par-4 protein plays an important role in neuronal apoptosis. This gene is upregulated in neuronal degeneration and is observed in Alzheimer′s disease.
The primary function of prostate apoptosis response 4 protein (Par-4) is to mediate apoptosis. In neuronal progenitor cells, ceramide and PAR-4 contribute to rapid apoptosis. PAR-4 activates the tumor necrosis factor receptor superfamily member (FAS)-based death signalling caspase cascade to accomplish apoptosis in prostate tumor cells. PAR-4 is considered as a potential drug for treatment of cancer and neurodegenerative disorders.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Storage and Stability

For continuous use, store at 2-8 °C for up to one month.For prolonged storage, freeze in working aliquots at −20 °C. Repeated freezing and thawing is not recom-mended. Storage in frost-free freezers is also notrecommended. If slight turbidity occurs upon prolongedstorage, clarify the solution by centrifugation beforeuse. Working dilutions should be discarded if not usedwithin 12 hours.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

R W Johnstone et al.
Molecular and cellular biology, 16(12), 6945-6956 (1996-12-01)
The tumor suppressor WT1 represses and activates transcription. The loss and/or imbalance of the dual transcriptional activity of WT1 may contribute to Wilms' tumor. In this study, we identified par-4 (for prostate apoptosis response) as a WT1-interacting protein that itself
Apoptosis by Par-4 in cancer and neurodegenerative diseases
El-Guendy N and Rangnekar VM
Experimental Cell Research, 283(1), 51-66 (2003)
Nikhil Hebbar et al.
Cancer research, 77(15), 4039-4050 (2017-06-20)
Primary tumors are often heterogeneous, composed of therapy-sensitive and emerging therapy-resistant cancer cells. Interestingly, treatment of therapy-sensitive tumors in heterogeneous tumor microenvironments results in apoptosis of therapy-resistant tumors. In this study, we identify a prostate apoptosis response-4 (Par-4) amino-terminal fragment
PAWR (PRKC apoptosis WT1 regulator protein; Prostate apoptosis response-4, Par-4
Shukla N, et al.
Atlas of Genetics and Cytogenetics in Oncology and Haematology (2016)
Structural and functional characterization of the upstream regulatory region of the human gene encoding prostate apoptosis response factor-4
Hsu SC, et al.
Gene, 295(1), 109-116 (2002)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service